Clinical Trial Update: Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating intravenous iron in patients with heart failure with reduced ejection fraction and iron deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Intravenous iron

Snippet

Sponsor: RWTH Aachen University | Conditions: Heart Failure, Systolic, Iron Deficiency | Phase 2 | Status: COMPLETED